Kymera Therapeutics Inc Earnings

The next earnings date for Kymera Therapeutics Inc has not yet been scheduled.

Analyst Estimates of Kymera Therapeutics Inc Earnings

No Results.
Report DateEstimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Kymera Therapeutics Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
10/29/2025Before Market------
08/01/2025---$0100.00%
04/30/2025Before Market$-0.82-12.33%
02/20/2025Before Market$-0.89-12.92%
10/31/2024Before Market$-0.822.38%
08/07/2024Before Market$-0.5814.71%
05/02/2024Before Market$-0.6215.07%
02/22/2024Before Market$-0.2537.50%
11/02/2023Before Market$-0.90-40.63%
08/03/2023Before Market$-0.675.63%
05/04/2023Before Market$-0.70-2.94%
02/23/2023Before Market$-0.604.76%
11/03/2022Before Market$-0.79-6.76%
08/09/2022Before Market$-0.78-11.43%
05/03/2022Before Market$-0.71-7.58%
02/24/2022Before Market$-0.66-15.79%
11/10/2021Before Market$-0.56-33.33%
08/06/2021Before Market$-0.55-89.66%
05/06/2021Before Market$-0.29-93.33%
03/11/2021Before Market$-0.29-625.00%
11/05/2020Before Market$-0.39-85.71%
08/21/2020After Market$-0.42---
06/22/2020---$-0.96---

More About Kymera Therapeutics Inc

Country
USA
Full Time Employees
225

Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase II clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa and atopic dermatitis. The company also develops STAT6, a type 2 inflammation in allergic and atopic diseases; and TYK2 to treat autoimmune and inflammatory diseases. The company has a strategic alliance with Sanofi S.A. for the development of drug candidates targeting IRAK4 outside of the oncology and immuno-oncology fields. Kymera Therapeutics, Inc. was incorporated in 2015 and is headquartered in Watertown, Massachusetts.

Kymera Therapeutics Inc Earnings” Can Refer to the Kymera Therapeutics Inc Earnings Date

Some people say “Kymera Therapeutics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Kymera Therapeutics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Kymera Therapeutics Inc Stock on the Earnings Date

If you own Kymera Therapeutics Inc stock (KYMR) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Kymera Therapeutics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Kymera Therapeutics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Kymera Therapeutics Inc Earnings

You can contact us any time if you would like to ask questions about Kymera Therapeutics Inc earnings or anything else related to the stock market.